Intimate partner violence (IPV) disproportionately impacts women and younger populations, with incidences peaking between adolescence and young adulthood.
Relay licenses cancer drug to Korean biotech for $75M
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS